Drug Approval Package: REBLOZYL
Company: Celgene Corporation
Application Number: 761136
Approval Date: 4/3/2020
Application Number: 761136
Approval Date: 4/3/2020
Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.
FDA Approval Letter and Labeling
- Approval Letter(s) (PDF)
- Printed Labeling (PDF)
FDA Application Review Files
- Clinical Pharmacology and Biopharmaceutics Review(s) (PDF)
- Clinical Review(s) (PDF)
- Non-Clinical Review(s) (PDF)
- Officer/Employee List (PDF)
- Office Director Memo (PDF)
- Other Review(s) (PDF)
- Statistical Review(s) (PDF)
- Summary Review (PDF)
- Administrative and Correspondence Documents (PDF)
Date created: October 08, 2020
Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.
Note: Documents in PDF format require the Adobe Acrobat Reader®.